Caris Life Sciences, Inc. CAI
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Caris Life Sciences is a leading AI-driven precision medicine company that transforms healthcare through comprehensive molecular profiling and advanced machine learning. The company specializes in analyzing cancer at the molecular level by performing whole exome and whole transcriptome sequencing on patient tissue and …
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees1,769
TickerCAI
Statistics
Market Cap$5.05B
Revenue (TTM)$812.0M
Net Income-$68.1M
Net Margin-8.4%
EPS$-2.76
P/E7.58
P/S5.31
P/B8.11
EV/EBITDA34.13
ROE28.4%
Dividend Yield—
Price$17.88
Data: Twelve Data · Revenue = mcap / P/S